Aclarion(us:ACON)

    0.1276

    +2.16%

    Updated on 2024-12-23

    Open:0.1290
    Close:0.1276
    High:0.1347
    Low:0.1211
    Pre Close:0.1249
    Volume:645252.00
    Amount:82412.45
    Turnover:6.18%
    Shares:10.44M
    MarketCap:1.33M
    FinancialsXXXX

    About

    Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.
    Address:8181 Arista Place,Suite 100

    Market Movers